These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 3172844)

  • 1. Differential expression of class II MHC antigens in subpopulations of human hematopoietic progenitor cells.
    Ottmann OG; Nocka KH; Moore MA; Pelus LM
    Leukemia; 1988 Oct; 2(10):677-86. PubMed ID: 3172844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.
    Lu L; Walker D; Broxmeyer HE; Hoffman R; Hu W; Walker E
    J Immunol; 1987 Sep; 139(6):1823-9. PubMed ID: 3114377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the expression of HLA-DR (Ia) antigens and the proliferation of human erythroid (BFU-E) and multipotential (CFU-GEMM) progenitor cells by prostaglandin E.
    Lu L; Pelus LM; Broxmeyer HE
    Exp Hematol; 1984 Oct; 12(9):741-8. PubMed ID: 6436046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells.
    Traycoff CM; Abboud MR; Laver J; Brandt JE; Hoffman R; Law P; Ishizawa L; Srour EF
    Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.
    Ottmann OG; Abboud M; Welte K; Souza LM; Pelus LM
    Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
    Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-class II antigens on human hematopoietic progenitors.
    Busch FW; Langer M; Pawelec G; Ziegler A; Wernet P; Bühring HJ; Meyer P; Müller C
    Blut; 1987 Mar; 54(3):179-88. PubMed ID: 2434163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant expression of human Ia-like antigens on hematopoietic progenitor cells.
    Linch DC; Nadler LM; Luther EA; Lipton JM
    J Immunol; 1984 May; 132(5):2324-9. PubMed ID: 6609195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between HLA-DR expression by normal myeloid progenitor cells and inhibition of colony growth by prostaglandin E. Implications for prostaglandin E resistance in chronic myeloid leukemia.
    Cannistra SA; Herrmann F; Davis R; Nichols K; Griffin JD
    J Clin Invest; 1986 Jan; 77(1):13-20. PubMed ID: 3455931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement-dependent cytotoxicity in the analysis of antigenic determinants on human hematopoietic progenitor cells with HLA-DR as a model.
    Falkenburg JH; van der Vaart-Duinkerken N; Veenhof WF; Goselink HM; van Eeden G; Parlevliet J; Jansen J
    Exp Hematol; 1984 Dec; 12(11):817-21. PubMed ID: 6210206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective expression of class-II MHC antigens during hemopoietic differentiation.
    Katz FE; Davis L; Myers CD; Greaves MF
    Exp Hematol; 1985 Dec; 13(11):1182-7. PubMed ID: 3864642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
    Broxmeyer HE; Lu L; Platzer E; Feit C; Juliano L; Rubin BY
    J Immunol; 1983 Sep; 131(3):1300-5. PubMed ID: 6193183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and quantitation of primitive hematopoietic progenitor cells present in peripheral blood autografts.
    Tong J; Hoffman R; Siena S; Srour EF; Bregni M; Gianni AM
    Exp Hematol; 1994 Sep; 22(10):1016-24. PubMed ID: 8088376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of early hematopoiesis in serum-deprived cultures of mafosfamide-treated and untreated CD34-enriched bone marrow cells.
    Ottmann OG; Stella CC; Eder M; Reutzel P; Ströcker S; Hoelzer D; Ganser A
    Exp Hematol; 1991 Sep; 19(8):773-8. PubMed ID: 1714403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates immature marrow precursors but no CFU-GM, CFU-G, or CFU-M.
    Bot FJ; van Eijk L; Schipper P; Löwenberg B
    Exp Hematol; 1989 Mar; 17(3):292-5. PubMed ID: 2645158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma.
    Lu L; Foa P; Chillemi F; Shen RN; Lin ZH; Carow C; Broxmeyer HE
    Exp Hematol; 1989 Oct; 17(9):935-41. PubMed ID: 2506072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture.
    Simmons PJ; Aylett GW; Niutta S; To LB; Juttner CA; Ashman LK
    Exp Hematol; 1994 Feb; 22(2):157-65. PubMed ID: 7507857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.